HOME >> MEDICINE >> NEWS
NIAID announces leadership for newly restructured HIV/AIDS clinical trials networks

The National Institute of Allergy and Infectious Diseases (NIAID) today announced the clinical investigators and institutions that will lead NIAID's newly restructured HIV/AIDS clinical trials networks in the search for safe and effective treatments and prevention strategies, including HIV vaccines. NIAID, part of the National Institutes of Health (NIH), supports the world's largest portfolio of clinical HIV/AIDS research.

"The new network structure expands our clinical research capacity and strengthens our ability to take advantage of emerging scientific opportunities," says NIAID Director Anthony S. Fauci, M.D. "By creating a more integrated, collaborative and flexible structure, we will be better equipped to meet evolving global AIDS research priorities."

These leadership group awards represent the first step of the two-part restructuring process of the HIV/AIDS clinical trials networks. Awards for the Clinical Trials Units (CTUs), which will carry out the clinical research, are expected to be announced later this year.

Each leadership group will be led by a principal investigator and include a core operations group that will provide administrative and technical support; a statistical and data management center; and a network laboratory structure. The following principal investigators and institutions will lead the newly restructured HIV/AIDS networks:

  • AIDS Clinical Trials Group (ACTG)--Constance A. Benson, M.D., University of California, San Diego
  • HIV Prevention Trials Network (HPTN)--Sten Vermund, M.D., Ph.D., Vanderbilt University, Nashville
  • HIV Vaccine Trials Network (HVTN)--Lawrence Corey, M.D., The Fred Hutchinson Cancer Research Center, Seattle
  • International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT)--Jay Brooks Jackson, M.D., Johns Hopkins University School of Medicine, Baltimore
  • Interna
    '"/>


Contact: Kathy Stover
kstover@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
29-Jun-2006


Page: 1 2 3

Related medicine news :

1. NIAID releases MDR/XDR Tuberculosis research agenda
2. NIAID DNA vaccine for H5N1 avian influenza enters human trial
3. NIAID media availability: Examining genetic variability of malaria parasite offers insight
4. NIAID awards $4 million to develop anti-radiation treatments
5. Partnership between NIAID and Sequella yields promising new TB drug for clinical testing
6. NIAID study finds higher dose of flu vaccine improves immune response in the elderly
7. NIAID media availability: New study describes key protein from highly pathogenic H5N1 avian flu virus and how it might mutate
8. NIAID media availability: Understanding influenza infection
9. NIAID researchers show how promising TB drug works
10. NIAID awards $47 million to develop medical countermeasures against radiological, nuclear threats
11. NIAID launches first Phase II trial of a global HIV/AIDS vaccine

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/22/2018)... ... 20, 2018 , ... A July 12 article in Glamour offers examples of six ... who obtained a weight loss surgery after she was moved to take more control of ... and a half years, she lost close to 90 pounds following her sleeve gastrectomy. “Bariatric ...
(Date:7/22/2018)... (PRWEB) , ... July 20, 2018 , ... Dr. Joseph ... groundbreaking medical devices for cardiology patients after retiring and resigning as a part-time adjunct ... , “I have enjoyed serving on the Johns Hopkins faculty for many ...
(Date:7/22/2018)... ... ... Novant Health is pleased to announce that Chad Setliff will be the new ... Setliff, who begins in the new role on Aug. 12, most recently served as ... Health Clemmons Medical Center. Before that, he was president and COO of Novant Health ...
(Date:7/22/2018)... ANGELES (PRWEB) , ... July 20, 2018 , ... Cosmetic Town, a Los Angeles based ... easier for patients. The website is starting the publication of a series of lists that ... , According to the senior editor of Cosmetic Town , “San Diego is often ...
(Date:7/22/2018)... ... July 21, 2018 , ... "Business Matrix" is a ... Now, in an upcoming episode, the program will focus on sports injury prevention. , ... healthy lifestyle, as well as to have fun or compete professionally. Unfortunately, all sports ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... , Oct. 10, 2017   West Pharmaceutical Services, ... solutions for injectable drug administration, today shared the results ... Adapter for improving the intradermal administration of polio vaccines. ... Vaccination Summit in May 2017 by Dr. Ondrej ... Department, World Health Organization (WHO), and recently published in ...
(Date:10/4/2017)... 2017 OBP Medical , a ... devices, today announced regulatory approval from ... Agência Nacional de Vigilância Sanitária (ANVISA)) to market ... retractor with integrated LED light source and smoke ... exposure of a tissue pocket or cavity during ...
(Date:10/2/2017)... 2017 The Rebound mobile app is poised to ... the tide of prescription drug addiction. The app empowers users ... and stepping down their dosage in a safe, controlled manner ... 2017; the first 100,000 people to sign up will enjoy ... ...
Breaking Medicine Technology:
Cached News: